Cancer drug may reduce Covid load in lungs by 99 per cent January 27, 2021 Spanish pharmaceutical company PharmaMar claims its cancer drug Aplidin has the potential to reduce any Covid-19 load in lungs by 99 per cent. Already authorised to treat tumours in some markets, Aplidin blocks a protein associated with the virus and prevents viral replication, leading to the near-complete eradication of Covid viral loads in the lungs [...]
